$SEEL News Article - Seelos Therapeutics Announces
Post# of 144499
(Total Views: 67)
Posted On: 06/22/2023 10:25:45 AM
$SEEL News Article - Seelos Therapeutics Announces the Close of Enrollment of its Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in Adults with Major Depressive Disorder (MDD) https://marketwirenews.com/news-releases/seel...04657.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼